Blood Loss Assessment in the Limited Application of Tourniquet During Primary Unilateral TKA
Arthritis Knee, Blood Loss, Arthroplasty Complications

About this trial
This is an interventional treatment trial for Arthritis Knee focused on measuring total knee arthroplasty, blood loss, tourniquet, complications
Eligibility Criteria
Inclusion Criteria: patients between 50 and 85 years of age with end-stage knee arthritis going primary unilateral TKA after the failure of conservative treatment. Exclusion Criteria: o Patients younger than 50y and older than 85y. BMI less than 20 and more than 35. Patients having a vascular or hematologic disease. Patients who were taking anti-coagulant medicine and can't stop it. Patients having acute or chronic renal failure. Patients classified as the AAA as grade four or five. Post-traumatic and secondary knee arthritis patients. Revisions and complex primary cases. Patients with an active infection or a history of lower limp infection.
Sites / Locations
- Damascus university
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
limited application
full-time application
Will go primary unilateral TKA with the tourniquet inflated only during cementation and final components of the prosthesis application
will go unilateral primary TKA with inflating the tourniquet prior to incision and releasing it after closure and compression bandage application